Salarius files ATM offering prospectus supplement for up to $335,921 in common stock

Decoy Therapeutics Inc.

Filed Prospectus Supplement on July 25, 2024 for at-the-market offering of up to $335,921 of common stock.
Offering conducted under prior S-3 registration statement (File No. 333-266589) declared effective August 16, 2022.
ATM agreement dated February 5, 2021 with Ladenburg Thalmann & Co. Inc. as sales agent.
Legal opinion of Hogan Lovells US LLP on share validity filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.